Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids
Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids
Date de publication/diffusion :
2023
Titre du périodique :
Cells
eISSN :
2073-4409
Maison d'édition :
Multidisciplinary Digital Publishing Institute (MDPI), Basel, Suisse
Tosi G. Duskey J.T. Kreuter J. Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier Expert Opin. Drug Deliv. 2020 17 23 32 10.1080/17425247.2020.1698544
Abbott N.J. Blood-brain barrier structure and function and the challenges for CNS drug delivery J. Inherit. Metab. Dis. 2013 36 437 449 10.1007/s10545-013-9608-0 23609350
Pardridge W.M. CSF, blood-brain barrier, and brain drug delivery Expert. Opin. Drug. Deliv. 2016 13 963 975 10.1517/17425247.2016.1171315 27020469
Saraiva C. Praça C. Ferreira R. Santos T. Ferreira L. Bernardino L. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases J. Control. Release 2016 10 34 47 10.1016/j.jconrel.2016.05.044 27208862
Lombardo S.M. Schneider M. Türeli A.E. Günday Türeli N. Key for crossing the BBB with nanoparticles: The rational design Beilstein J. Nanotechnol. 2020 11 866 883 10.3762/bjnano.11.72
Masserini M. Nanoparticles for brain drug delivery ISRN Biochem. 2013 21 238428 10.1155/2013/238428
Duro-Castano A. Moreira Leite D. Forth J. Deng Y. Matias D. Noble Jesus C. Battaglia G. Designing peptide nanoparticles for efficient brain delivery Adv. Drug Deliv. Rev. 2020 160 52 77
Zagorodko O. Arroyo-Crespo J.J. Nebot V.J. Vicent M.J. Polypeptide-Based Conjugates as Therapeutics: Opportunities and Challenges Macromol. Biosci. 2017 17 1 10.1002/mabi.201600316
Pham T.N. Su C.F. Huang C.C. Jan J.S. Biomimetic hydrogels based on L-Dopa conjugated gelatin as pH-responsive drug carriers and antimicrobial agents Colloids Surf. B. Biointerfaces 2020 196 111316 10.1016/j.colsurfb.2020.111316
Chen Y.F. Chang C.H. Lin C.Y. Lin L.F. Yeh M.L. Jan J.S. Disulfide-cross-linked PEG-block-polypeptide nanoparticles with high drug loading content as glutathione-triggered anticancer drug nanocarriers Colloids Surf. B. Biointerfaces. 2018 165 172 181 10.1016/j.colsurfb.2018.02.042
Johnson L.C. Akinmola A.T. Scholz C. Poly(glutamic acid): From natto to drug delivery systems Biocatal. Agric. Biotechnol. 2022 40 102292 10.1016/j.bcab.2022.102292
Su C.F. Chen Y.F. Tsai Y.J. Weng S.M. Jan J.S. Antioxidant activity of linear and star-shaped polypeptides modified with dopamine and glutathione Eur. Polym. J. 2021 152 110497 10.1016/j.eurpolymj.2021.110497
Salmasi Z. Mokhtarzadeh A. Hashemi M. Ebrahimian M. Farzad S.A. Parhiz H. Ramezani M. Effective and safe in vivo gene delivery based on polyglutamic acid complexes with heterocyclic amine modified-polyethylenimine Colloids Surf. B. Biointerfaces. 2018 172 790 796 10.1016/j.colsurfb.2018.09.028 30268055
Wohlfart S. Gelperina S. Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles J. Control. Release 2012 161 264 273 10.1016/j.jconrel.2011.08.017
Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? Adv. Drug. Deliv. Rev. 2014 71 2 14 10.1016/j.addr.2013.08.008
Walter F.R. Santa-Maria A.R. Mészáros M. Veszelka S. Dér A. Deli M.A. Surface charge, glycocalyx, and blood-brain barrier function Tissue Barriers 2021 9 1904773 10.1080/21688370.2021.1904773
Sánchez-Navarro M. Teixidó M. Giralt E. Jumping Hurdles: Peptides Able to Overcome Biological Barriers Acc. Chem. Res. 2017 50 1847 1854 10.1021/acs.accounts.7b00204 28715199
He L. Vanlandewijck M. Mäe M.A. Andrae J. Ando K. Del Gaudio F. Nahar K. Lebouvier T. Laviña B. Gouveia L. et al. Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types Sci. Data 2018 21 180160 10.1038/sdata.2018.160
Vanlandewijck M. He L. Mäe M.A. Andrae J. Ando K. Del Gaudio F. Nahar K. Lebouvier T. Laviña B. Gouveia L. et al. A molecular atlas of cell types and zonation in the brain vasculature Nature 2018 554 475 480 10.1038/nature25739
Database of Gene Expression in Adult Mouse Brain and Lung Vascular and Perivascular Cells Available online: https://betsholtzlab.org/VascularSingleCells/database.html (accessed on 15 September 2022)
Veszelka S. Tóth A. Walter F.R. Tóth A.E. Gróf I. Mészáros M. Bocsik A. Hellinger É. Vastag M. Rákhely G. et al. Comparison of a rat primary cell-based blood-brain barrier model with epithelial and brain endothelial cell lines: Gene expression and drug transport Front. Mol. Neurosci. 2018 11 166 10.3389/fnmol.2018.00166 29872378
Campos-Bedolla P. Walter F.R. Veszelka S. Deli M.A. Role of the blood-brain barrier in the nutrition of the central nervous system Arch. Med. Res. 2014 45 610 638
Mc Carthy D.J. Malhotra M. O’Mahony A.M. Cryan J.F. O’Driscoll C.M. Nanoparticles and the blood-brain barrier: Advancing from in-vitro models towards therapeutic significance Pharm. Res. 2015 32 1161 1185 10.1007/s11095-014-1545-6 25446769
Kreuter J. Hekmatara T. Dreis S. Vogel T. Gelperina S. Langer K. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain J. Control. Release 2007 118 54 58 10.1016/j.jconrel.2006.12.012 17250920
Dal Magro R. Albertini B. Beretta S. Rigolio R. Donzelli E. Chiorazzi A. Ricci M. Blasi P. Sancini G. Artificial apolipoprotein corona enables nanoparticle brain targeting Nanomedicine 2018 14 429 438 10.1016/j.nano.2017.11.008 29157979
Topal G.R. Mészáros M. Porkoláb G. Szecskó A. Polgár T.F. Siklós L. Deli M.A. Veszelka S. Bozkir A. ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood-Brain Barrier Pharmaceutics. 2020 29 38 10.3390/pharmaceutics13010038
Ulbrich K. Hekmatara T. Herbert E. Kreuter J. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) Eur. J. Pharm. Biopharm. 2009 71 251 256 10.1016/j.ejpb.2008.08.021
Johnsen K.B. Burkhart A. Thomsen L.B. Andresen T.L. Moos T. Targeting the transferrin receptor for brain drug delivery Prog. Neurobiol. 2019 181 101665
Ulbrich K. Knobloch T. Kreuter J. Targeting the insulin receptor: Nanoparticles for drug delivery across the blood-brain barrier (BBB) J. Drug Target 2011 19 125 132 10.3109/10611861003734001 20387992
Kannan R. Mittur A. Bao Y. Tsuruo T. Kaplowitz N. GSH transport in immortalized mouse brain endothelial cells: Evidence for apical localization of a sodium-dependent GSH transporter J. Neurochem. 1999 73 390 399 10.1046/j.1471-4159.1999.0730390.x
Gaillard P.J. BBB crossing assessment and BBB crossing technologies in CNS Drug Discovery Drug Discov. Today Technol. 2016 20 1 3 10.1016/j.ddtec.2016.11.002 27986217
Birngruber T. Raml R. Gladdines W. Gatschelhofer C. Gander E. Ghosh A. Kroath T. Gaillard P.J. Pieber T.R. Sinner F. Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,(®)/Doxil(®)-a cerebral open flow microperfusion pilot study J. Pharm. Sci. 2014 103 1945 1948 10.1002/jps.23994
Kanhai K.M.S. Zuiker R.G.J.A. Stavrakaki I. Gladdines W. Gaillard P.J. Klaassen E.S. Groeneveld G.J. Glutathione-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: Slow release characteristics and prolonged lymphocyte depression in a first-in-human study Br. J. Clin. Pharmacol. 2018 84 1020 1028 10.1111/bcp.13525
Veszelka S. Mészáros M. Kiss L. Kóta Z. Páli T. Hoyk Z. Bozsó Z. Fülöp L. Tóth A. Rákhely G. et al. Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells Curr. Pharm. Des. 2017 23 4198 4205 10.2174/1381612823666170727144450 28748755
Fekete T. Mészáros M. Szegletes Z. Vizsnyiczai G. Zimányi L. Deli M.A. Veszelka S. Kelemen L. Optically Manipulated Microtools to Measure Adhesion of the Nanoparticle-Targeting Ligand Glutathione to Brain Endothelial Cells ACS Appl. Mater. Interfaces 2021 13 39018 39029 10.1021/acsami.1c08454
Dufes C. Gaillard F. Uchegbu I.F. Schätzlein A.G. Olivier J.C. Muller J.M. Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain Int. J. Pharm. 2004 285 77 85 10.1016/j.ijpharm.2004.07.020
Bragagni M. Mennini N. Ghelardini C. Mura P. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting J. Pharm. Pharm. Sci. 2012 15 184 196 10.18433/J3230M
Woods S. O’Brien L.M. Butcher W. Preston J.E. Georgian A.R. Williamson E.D. Salguero F.J. Modino F. Abbott N.J. Roberts C.W. et al. Glucosamine-NISV delivers antibody across the blood-brain barrier: Optimization for treatment of encephalitic viruses J. Control. Release 2020 324 644 656 10.1016/j.jconrel.2020.05.048
Gromnicova R. Davies H.A. Sreekanthreddy P. Romero I.A. Lund T. Roitt I.M. Phillips J.B. Male D.K. Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro PLoS ONE 2013 8 e81043 10.1371/journal.pone.0081043 24339894
Gromnicova R. Kaya M. Romero I.A. Williams P. Satchell S. Sharrack B. Male D. Transport of gold nanoparticles by vascular endothelium from different human tissues PLoS ONE 2016 11 e0161610 10.1371/journal.pone.0161610 27560685
Fatima N. Gromnicova R. Loughlin J. Sharrack B. Male D. Gold nanocarriers for transport of oligonucleotides across brain endothelial cells PLoS ONE 2020 15 e0236611 10.1371/journal.pone.0236611
Gonzalez-Carter D.A. Ong Z.Y. McGilvery C.M. Dunlop I.E. Dexter D.T. Porter A.E. L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles Nanomedicine 2019 15 1 11 10.1016/j.nano.2018.08.011 30189294
Mészáros M. Porkoláb G. Kiss L. Pilbat A.M. Kóta Z. Kupihár Z. Kéri A. Galbács G. Siklós L. Tóth A. et al. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier Eur. J. Pharm. Sci. 2018 123 228 240 10.1016/j.ejps.2018.07.042 30031862
Porkoláb G. Mészáros M. Tóth A. Szecskó A. Harazin A. Szegletes Z. Ferenc G. Blastyák A. Mátés L. Rákhely G. et al. Combination of Alanine and Glutathione as Targeting Ligands of Nanoparticles Enhances Cargo Delivery into the Cells of the Neurovascular Unit Pharmaceutics 2020 12 635 10.3390/pharmaceutics12070635 32645904
Shen X.Y. Tang C.C. Jan J.S. Synthesis and hydrogelation of star-shaped poly(l-lysine) polypeptides modified with different functional groups Polymer 2018 51 108 116 10.1016/j.polymer.2018.07.051
Huang C.C. Phan T.H.M. Ooya T. Kawasaki S. Lin B.-Y. Jan J.-S. Effect of Tethered Sheet-like Motif and Asymmetric Topology on Hydrogelation of Star-Shaped Block Copolypeptides Polymer 2022 250 124864 10.1016/j.polymer.2022.124864
Tang C.C. Zhang S.H. My Phan T.H. Tseng Y.-C. Jan J.S. Block Length and To-pology Affect Self-Assembly and Gelation of Poly(L-lysine)-block- Poly(S-benzyl-L-cysteine) Block Copolypeptides Polymer 2021 228 123891 10.1016/j.polymer.2021.123891
Zhu Y. Wang J. Li X. Zhao D. Sun J. Liu X. Self-assembly and emulsification of dopamine-modified hyaluronan Carbohydr. Polym. 2015 123 72 79 10.1016/j.carbpol.2015.01.030
Cecchelli R. Aday S. Sevin E. Almeida C. Culot M. Dehouck L. Coisne C. Engelhardt B. Dehouck M.P. Ferreira L. A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells PLoS ONE 2014 17 e99733 10.1371/journal.pone.0099733
Mossu A. Rosito M. Khire T. Li Chung H. Nishihara H. Gruber I. Luke E. Dehouck L. Sallusto F. Gosselet F. et al. A silicon nanomembrane platform for the visualization of immune cell trafficking across the human blood-brain barrier under flow J Cereb. Blood Flow Metab. 2019 39 395 410 10.1177/0271678X18820584
Nickels S.L. Modamio J. Mendes-Pinheiro B. Monzel A.S. Betsou F. Schwamborn J.C. Reproducible generation of humanmidbrain organoids for in vitro modeling of Parkinson’s disease Stem Cell Res. 2020 46 101870 10.1016/j.scr.2020.101870
Veszelka S. Mészáros M. Porkoláb G. Szecskó A. Kondor N. Ferenc G. Polgár T.F. Katona G. Kóta Z. Kelemen L. et al. A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model Pharmaceutics 2022 14 86 10.3390/pharmaceutics14010086
Schindelin J. Arganda-Carreras I. Frise E. Kaynig V. Longair M. Pietzsch T. Preibisch S. Rueden C. Saalfeld S. Schmid B. et al. Fiji: An open-source platform for biological-image analysis Nat. Methods 2012 9 676 682 10.1038/nmeth.2019 22743772
Rennick J.J. Johnston A.P.R. Parton R.G. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics Nat. Nanotechnol. 2021 16 266 276 10.1038/s41565-021-00858-8
Moya E.L.J. Lombardo S.M. Vandenhaute E. Schneider M. Mysiorek C. Türeli A.E. Kanda T. Shimizu F. Sano Y. Maubon N. et al. Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells Int. J. Pharm. 2022 10 121780 10.1016/j.ijpharm.2022.121780
Oldham E.A. Li C. Ke S. Wallace S. Huang P. Comparison of action of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in human breast cancer cells Int. J. Oncol. 2000 16 125 132 10.3892/ijo.16.1.125 10601557
Niño-Pariente A. Armiñán A. Reinhard S. Scholz C. Kos P. Wagner E. Vicent M.J. Design of Poly-l-Glutamate-Based Complexes for pDNA Delivery Macromol. Biosci. 2017 17 10 10.1002/mabi.201700029
Duro-Castano A. Nebot V.J. Niño-Pariente A. Armiñán A. Arroyo-Crespo J.J. Paul A. Feiner-Gracia N. Albertazzi L. Vicent M.J. Capturing "Extraordinary" Soft-Assembled Charge-Like Polypeptides as a Strategy for Nanocarrier Design Adv. Mater. 2017 29 39 10.1002/adma.201702888 28834624
Mamdouh Z. Giocondi M.C. Laprade R. Le Grimellec C. Temperature dependence of endocytosis in renal epithelial cells in culture Biochim. Biophys. Acta. 1996 1282 171 173 10.1016/0005-2736(96)00077-6
Maussang D. Rip J. van Kregten J. van den Heuvel A. van der Pol S. van der Boom B. Reijerkerk A. Chen L. de Boer M. Gaillard P. et al. Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo Drug Discov. Today Technol. 2016 20 59 69 10.1016/j.ddtec.2016.09.003
Santa-Maria A.R. Walter F.R. Figueiredo R. Kincses A. Vigh J.P. Heymans M. Culot M. Winter P. Gosselet F. Dér A. et al. Flow induces barrier and glycocalyx-related genes and negative surface charge in a lab-on-a-chip human blood-brain barrier model J. Cereb. Blood Flow Metab. 2021 41 2201 2215 10.1177/0271678X21992638
Nelemans L.C. Gurevich L. Drug Delivery with Polymeric Nanocarriers-Cellular Uptake Mechanisms Materials 2020 13 366 10.3390/ma13020366 31941006
Toth A.E. Holst M.R. Nielsen M.S. Vesicular Transport Machinery in Brain Endothelial Cells: What We Know and What We Do not Curr. Pharm. Des. 2020 26 1405 1416 10.2174/1381612826666200212113421 32048959
Johnsen K.B. Bak M. Kempen P.J. Melander F. Burkhart A. Thomsen M.S. Nielsen M.S. Moos T. Andresen T.L. Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles Theranostics. 2018 8 3416 3436 10.7150/thno.25228
Leite P.E.C. Pereira M.R. Harris G. Pamies D. Dos Santos L.M.G. Granjeiro J.M. Hogberg H.T. Hartung T. Smirnova L. Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery Part Fibre Toxicol. 2019 16 22 10.1186/s12989-019-0307-3 31159811
Modamio J. Saraiva C. Giro G.G. Nickels S.L. Jarazo J. Antony P. Barbuti P. Hadler R. Jäger C. Krüger R. et al. Synaptic decline precedes dopaminergic neuronal loss in human midbrain organoids harboring a triplication of the SNCA gene bioRxiv 2021 452499 10.1101/2021.07.15.452499
Smits L.M. Schwamborn J.C. Midbrain Organoids: A New Tool to Investigate Parkinson’s Disease Front. Cell Dev. Biol. 2020 8 359 10.3389/fcell.2020.00359
